SGP
SpyGlass Pharma Inc.

32
Mkt Cap
$866.25M
Volume
728,530.00
52W High
$32.44
52W Low
$16.00
Price
$26.00
SGP Fundamentals
Prev Close
$25.71
Open
$25.30
50D MA
$27.07
Beta
0.00
Avg. Volume
161,020.63
EPS (Annual)
-$0.9139
P/B
-13.72
Loading...
Loading...
News
all
press releases
HC Wainwright Estimates Spyglass Pharma FY2025 Earnings
Spyglass Pharma, Inc. (NASDAQ:SGP - Free Report) - Stock analysts at HC Wainwright issued their FY2025 earnings per share (EPS) estimates for Spyglass Pharma in a research report issued on Tuesday...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Spyglass Pharma, Inc.'s Quiet Period Will Expire on March 18th (NASDAQ:SGP)
Spyglass Pharma's (NASDAQ:SGP - Get Free Report) quiet period will expire on Wednesday, March 18th. Spyglass Pharma had issued 9,375,000 shares in its public offering on February 6th. The total size...
MarketBeat·10d ago
News Placeholder
Spyglass Pharma (NASDAQ:SGP) Coverage Initiated by Analysts at HC Wainwright
HC Wainwright began coverage on shares of Spyglass Pharma in a research note on Tuesday. They set a "buy" rating and a $37.00 price target for the company...
MarketBeat·11d ago
News Placeholder
Spyglass Pharma (NASDAQ:SGP) Trading 5.3% Higher - Here's What Happened
Spyglass Pharma (NASDAQ:SGP) Shares Up 5.3% - What's Next...
MarketBeat·14d ago
News Placeholder
Spyglass Pharma (NASDAQ:SGP) Rating Increased to Hold at Zacks Research
Zacks Research raised Spyglass Pharma to a "hold" rating in a research report on Wednesday...
MarketBeat·15d ago
News Placeholder
Spyglass Pharma (NASDAQ:SGP) Rating Increased to Strong-Buy at Jefferies Financial Group
Jefferies Financial Group upgraded shares of Spyglass Pharma to a "strong-buy" rating in a research note on Tuesday...
MarketBeat·17d ago
News Placeholder
Citigroup Initiates Coverage on Spyglass Pharma (NASDAQ:SGP)
Citigroup initiated coverage on Spyglass Pharma in a research note on Tuesday. They issued a "buy" rating and a $42.00 target price for the company...
MarketBeat·18d ago
News Placeholder
Spyglass Pharma (NASDAQ:SGP) Earns Outperform Rating from Analysts at Leerink Partners
Leerink Partners assumed coverage on shares of Spyglass Pharma in a research report on Tuesday. They set an "outperform" rating and a $42.00 price target for the company...
MarketBeat·18d ago
News Placeholder
Spyglass Pharma (NASDAQ:SGP) Director Acquires $59,040,000.00 in Stock
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) Director Ra Capital Management, L.P. purchased 3,690,000 shares of the stock in a transaction dated Monday, February 9th. The shares were acquired...
MarketBeat·1mo ago
<
...
1
>

Latest SGP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.